FHB
NBIX icon

First Hawaiian Bank’s Neurocrine Biosciences NBIX Stock Holding History

First Hawaiian Bank’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,243
Closed -$1.67M – 517
2024
Q4 		$1.67M Buy
12,243
+2,150
+21% +$266K 0.05% 272
2024
Q3 		$1.16M Buy
10,093
+4,610
+84% +$632K 0.04% 382
2024
Q2 		$755K Buy
5,483
+320
+6% +$43.9K 0.03% 442
2024
Q1 		$712K Sell
5,163
-105
-2% -$14.3K 0.02% 503
2023
Q4 		$694K Buy
5,268
+1,685
+47% +$194K 0.02% 495
2023
Q3 		$403K Buy
3,583
+900
+34% +$94.8K 0.01% 634
2023
Q2 		$253K Sell
2,683
-8,750
-77% -$855K 0.01% 756
2023
Q1 		$1.16M Sell
11,433
-3,195
-22% -$332K 0.04% 332
2022
Q4 		$1.75M Sell
14,628
-650
-4% -$76.1K 0.06% 235
2022
Q3 		$1.62M Buy
15,278
+15
+0.1% +$1.52K 0.06% 222
2022
Q2 		$1.49M Buy
15,263
+6,435
+73% +$594K 0.05% 253
2022
Q1 		$827K Buy
8,828
+35
+0.4% +$2.97K 0.03% 442
2021
Q4 		$749K Buy
+8,793
New +$809K 0.02% 477
2021
Q1 		– Sell
-3,078
Closed -$295K – 862
2020
Q4 		$295K Sell
3,078
-145
-4% -$14K 0.01% 666
2020
Q3 		$310K Buy
+3,223
New +$373K 0.02% 587
2019
Q2 		– Sell
-127
Closed -$11K – 1242
2019
Q1 		$11K Sell
127
-241
-65% -$20.1K ﹤0.01% 1374
2018
Q4 		$26K Buy
368
+58
+19% +$5.56K ﹤0.01% 1244
2018
Q3 		$38K Buy
+310
New +$35.2K ﹤0.01% 1228

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Hawaiian Bank's NBIX Position: Q1 2025 in Review

First Hawaiian Bank sold out of Neurocrine Biosciences (NBIX) in Q1 2025, closing a stake of 12,243 shares — an estimated $1.67M sold.

First Hawaiian Bank first reported a position in NBIX in Q3 2018 and held it in 18 quarters. The position peaked at $1.75M in Q4 2022. 586 funds tracked by Wall St. Rank hold NBIX as of Q1 2025.

  • First Hawaiian Bank reported no remaining Neurocrine Biosciences position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 12,243 Neurocrine Biosciences shares in Q1 2025, an estimated $1.67M.
  • First Hawaiian Bank first reported a position in Neurocrine Biosciences in Q3 2018 and held it in 18 quarters.
  • First Hawaiian Bank's Neurocrine Biosciences position peaked at $1.75M in Q4 2022.
  • 586 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.